Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$103.37
+0.5%
$109.56
$77.56
$116.04
$25.14B0.682.28 million shs2.48 million shs
Hologic, Inc. stock logo
HOLX
Hologic
$77.19
+1.3%
$75.87
$64.02
$87.88
$18.12B11.80 million shs1.60 million shs
McKesson Co. stock logo
MCK
McKesson
$531.87
+0.9%
$526.12
$352.34
$543.00
$69.89B0.45687,474 shs490,759 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+0.53%-3.56%-6.88%-0.95%+27.62%
Hologic, Inc. stock logo
HOLX
Hologic
+1.27%+2.77%+2.56%+4.18%-9.85%
McKesson Co. stock logo
MCK
McKesson
+0.77%+0.65%-0.13%+9.66%+46.96%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.2679 of 5 stars
1.33.03.33.62.61.73.1
Hologic, Inc. stock logo
HOLX
Hologic
4.7451 of 5 stars
3.24.00.04.22.62.52.5
McKesson Co. stock logo
MCK
McKesson
4.8323 of 5 stars
2.45.03.33.02.92.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.55
Moderate Buy$103.07-0.29% Downside
Hologic, Inc. stock logo
HOLX
Hologic
2.44
Hold$87.0012.71% Upside
McKesson Co. stock logo
MCK
McKesson
2.83
Moderate Buy$533.500.31% Upside

Current Analyst Ratings

Latest CAH, MCK, and HOLX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
McKesson Co. stock logo
MCK
McKesson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$522.00 ➝ $548.00
4/10/2024
Hologic, Inc. stock logo
HOLX
Hologic
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$90.00
4/10/2024
McKesson Co. stock logo
MCK
McKesson
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$510.00 ➝ $570.00
4/4/2024
Hologic, Inc. stock logo
HOLX
Hologic
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$76.00 ➝ $78.00
4/3/2024
Hologic, Inc. stock logo
HOLX
Hologic
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$80.00 ➝ $95.00
3/6/2024
McKesson Co. stock logo
MCK
McKesson
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$575.00 ➝ $620.00
2/26/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$125.00
2/26/2024
McKesson Co. stock logo
MCK
McKesson
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024
McKesson Co. stock logo
MCK
McKesson
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$600.00
2/9/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$205.01B0.12$8.30 per share12.46($11.20) per share-9.23
Hologic, Inc. stock logo
HOLX
Hologic
$4.03B4.50$5.47 per share14.12$20.48 per share3.77
McKesson Co. stock logo
MCK
McKesson
$276.71B0.25$32.65 per share16.29($10.99) per share-48.40

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$261M$2.5440.7012.861.040.30%-57.44%3.89%5/2/2024 (Confirmed)
Hologic, Inc. stock logo
HOLX
Hologic
$456M$2.1136.5817.662.5512.98%18.91%10.47%5/2/2024 (Confirmed)
McKesson Co. stock logo
MCK
McKesson
$3.56B$22.0724.1017.141.420.99%-262.63%5.96%5/7/2024 (Confirmed)

Latest CAH, MCK, and HOLX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
McKesson Co. stock logo
MCK
McKesson
$6.39N/A-$6.39N/AN/AN/A  
5/2/2024N/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.96N/A-$1.96N/AN/AN/A  
5/2/2024N/A
Hologic, Inc. stock logo
HOLX
Hologic
$0.98N/A-$0.98N/AN/AN/A  
2/7/2024Q3 2024
McKesson Co. stock logo
MCK
McKesson
$7.05$7.74+$0.69$11.06$77.93 billion$80.90 billion    
2/1/2024Q2 2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.56$1.82+$0.26$2.21$57.02 billion$57.45 billion    
2/1/2024Q1 24
Hologic, Inc. stock logo
HOLX
Hologic
$0.95$0.98+$0.03$0.93$989.32 million$1.01 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.001.93%+1.00%78.74%27 Years
Hologic, Inc. stock logo
HOLX
Hologic
N/AN/AN/AN/AN/A
McKesson Co. stock logo
MCK
McKesson
$2.480.47%+11.80%11.24%16 Years

Latest CAH, MCK, and HOLX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/6/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.50061.92%3/28/20244/1/20244/15/2024
2/1/2024
McKesson Co. stock logo
MCK
McKesson
quarterly$0.620.5%2/29/20243/1/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.98
0.50
Hologic, Inc. stock logo
HOLX
Hologic
0.55
3.89
3.18
McKesson Co. stock logo
MCK
McKesson
N/A
0.92
0.50

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
Hologic, Inc. stock logo
HOLX
Hologic
94.73%
McKesson Co. stock logo
MCK
McKesson
85.07%

Insider Ownership

CompanyInsider Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.15%
Hologic, Inc. stock logo
HOLX
Hologic
1.75%
McKesson Co. stock logo
MCK
McKesson
0.21%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
48,000243.23 million242.87 millionOptionable
Hologic, Inc. stock logo
HOLX
Hologic
6,990234.73 million230.62 millionOptionable
McKesson Co. stock logo
MCK
McKesson
51,000131.41 million131.13 millionOptionable

CAH, MCK, and HOLX Headlines

SourceHeadline
VIDEO: Maryland officer hits suspect 8 times in head after being spat onVIDEO: Maryland officer hits suspect 8 times in head after being spat on
wpde.com - April 23 at 10:45 PM
BLM activist DeRay McKesson still hounded by wild lawsuitBLM activist DeRay McKesson still hounded by 'wild' lawsuit
baltimoresun.com - April 23 at 5:45 PM
McKesson Co. (NYSE:MCK) Shares Sold by New York State Common Retirement FundMcKesson Co. (NYSE:MCK) Shares Sold by New York State Common Retirement Fund
marketbeat.com - April 23 at 12:28 PM
Q2 2025 Earnings Estimate for McKesson Co. Issued By Leerink Partnrs (NYSE:MCK)Q2 2025 Earnings Estimate for McKesson Co. Issued By Leerink Partnrs (NYSE:MCK)
marketbeat.com - April 23 at 6:31 AM
Buy Rating Affirmed: McKesson’s Strategic Growth Bolstered by OptumRx Contract WinBuy Rating Affirmed: McKesson’s Strategic Growth Bolstered by OptumRx Contract Win
markets.businessinsider.com - April 23 at 3:10 AM
The Supreme Court Declined a Protestors Rights Case. Heres What You Need to Know.The Supreme Court Declined a Protestors' Rights Case. Here's What You Need to Know.
aclu.org - April 22 at 10:10 PM
Wedge Capital Management L L P NC Sells 9,263 Shares of McKesson Co. (NYSE:MCK)Wedge Capital Management L L P NC Sells 9,263 Shares of McKesson Co. (NYSE:MCK)
marketbeat.com - April 22 at 6:08 PM
Car­di­nal Health los­es Op­tum­Rx con­tract to McKessonCar­di­nal Health los­es Op­tum­Rx con­tract to McKesson
endpts.com - April 22 at 5:07 PM
The Top 3 Healthcare Stocks to Buy in April 2024The Top 3 Healthcare Stocks to Buy in April 2024
investorplace.com - April 22 at 4:02 PM
Drug distributor Cardinal Health to lose OptumRx contractsDrug distributor Cardinal Health to lose OptumRx contracts
msn.com - April 22 at 12:05 PM
Ardevora Asset Management LLP Has $10.36 Million Stock Position in McKesson Co. (NYSE:MCK)Ardevora Asset Management LLP Has $10.36 Million Stock Position in McKesson Co. (NYSE:MCK)
marketbeat.com - April 21 at 9:14 PM
McKesson Co. (NYSE:MCK) Given Average Rating of "Moderate Buy" by AnalystsMcKesson Co. (NYSE:MCK) Given Average Rating of "Moderate Buy" by Analysts
americanbankingnews.com - April 21 at 2:30 AM
Pilot program seeking support to provide housing, food and transportation for DFW cancer patientsPilot program seeking support to provide housing, food and transportation for DFW cancer patients
msn.com - April 20 at 7:32 PM
McKesson Co. (NYSE:MCK) Shares Sold by Federated Hermes Inc.McKesson Co. (NYSE:MCK) Shares Sold by Federated Hermes Inc.
marketbeat.com - April 20 at 7:16 AM
Jeopardizing the right to protest, Supreme Court refuses to block lawsuit by police officer against demonstration organizerJeopardizing the right to protest, Supreme Court refuses to block lawsuit by police officer against demonstration organizer
wsws.org - April 19 at 10:59 PM
Geneva Partners LLC Sells 1,890 Shares of McKesson Co. (NYSE:MCK)Geneva Partners LLC Sells 1,890 Shares of McKesson Co. (NYSE:MCK)
marketbeat.com - April 19 at 10:54 PM
Supreme Court Sides With Police Officer’s Lawsuit, Rejects Black Lives Matter Activist’s First Amendment AppealSupreme Court Sides With Police Officer’s Lawsuit, Rejects Black Lives Matter Activist’s First Amendment Appeal
blackenterprise.com - April 19 at 12:58 PM
Why McKesson (MCK) is a Top Value Stock for the Long-TermWhy McKesson (MCK) is a Top Value Stock for the Long-Term
zacks.com - April 19 at 10:40 AM
The Breakdown: SCOTUS decision upholds liability of protest organizers in LA, MS, TXThe Breakdown: SCOTUS decision upholds liability of protest organizers in LA, MS, TX
msn.com - April 19 at 1:47 AM
Tag Archives: DeRay MckessonTag Archives: DeRay Mckesson
southseattleemerald.com - April 18 at 3:05 PM
Supreme Court Is Apparently Fine with the Assault on the First Amendment That Is Mckesson v. DoeSupreme Court Is Apparently Fine with the Assault on the First Amendment That Is Mckesson v. Doe
msn.com - April 18 at 3:05 PM
Supreme Court To Allow Lawsuit Against BLM Activist To Move ForwardSupreme Court To Allow Lawsuit Against BLM Activist To Move Forward
msn.com - April 18 at 3:05 PM
OPINION | SCOTUS Ruling Threatens the Right to Protest in 3 States. Here’s What It Means for the Rest of UsOPINION | SCOTUS Ruling Threatens the Right to Protest in 3 States. Here’s What It Means for the Rest of Us
southseattleemerald.com - April 18 at 3:05 PM
Ninety One UK Ltd Lowers Position in McKesson Co. (NYSE:MCK)Ninety One UK Ltd Lowers Position in McKesson Co. (NYSE:MCK)
marketbeat.com - April 18 at 1:50 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cardinal Health logo

Cardinal Health

NYSE:CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Hologic logo

Hologic

NASDAQ:HOLX
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
McKesson logo

McKesson

NYSE:MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.